Kaya Holdings (KAYS) Return on Capital Employed (2012 - 2025)
Kaya Holdings (KAYS) recorded quarterly Return on Capital Employed of 49.45% in Q3 2025, up 206.36% quarter-over-quarter from 16.14% in Q2 2025, and up 2993.0% on a YoY basis from 1.6% in Q3 2024.
Kaya Holdings (KAYS) Return on Capital Employed (2012 - 2025) Analysis & Trends
Kaya Holdings' Return on Capital Employed history runs 13 years deep, the most recent figure standing at 49.45% for Q3 2025.
- In Q3 2025, Return on Capital Employed rose 2993.0% year-over-year to 49.45%; the TTM figure through Sep 2025 stood at 49.45% (up 2993.0% YoY), while the FY2024 annual figure was 25.64%, up 1076.0% from the prior year.
- Return on Capital Employed was 49.45% for Q3 2025 at Kaya Holdings, up from 16.14% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 49.45% in Q3 2025 to a low of 7.7% in Q1 2021.
- Historically, Return on Capital Employed has averaged 19.62% across 5 years, with a median of 18.12% in 2023.
- The sharpest annual moves came in 2023 and 2025: Return on Capital Employed plunged 1508 bps in 2023, then soared 2993 bps in 2025.
- A 5-year view of Return on Capital Employed shows it stood at 23.04% in 2021, then fell by 22 bps to 17.99% in 2022, then decreased by 21 bps to 14.24% in 2023, then soared by 81 bps to 25.72% in 2024, then jumped by 92 bps to 49.45% in 2025.
- The last three Return on Capital Employed figures came in at 49.45% (Q3 2025), 16.14% (Q2 2025), and 22.14% (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | Kaya Holdings | - | - | 5,370.00 | 49.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 49.45% |
| Jun 30, 2025 | 16.14% |
| Mar 31, 2025 | 22.14% |
| Dec 31, 2024 | 25.72% |
| Sep 30, 2024 | 19.53% |
| Jun 30, 2024 | 12.67% |
| Mar 31, 2024 | 11.48% |
| Dec 31, 2023 | 14.24% |
| Sep 30, 2023 | 23.49% |
| Jun 30, 2023 | 18.12% |
| Mar 31, 2023 | 18.85% |
| Dec 31, 2022 | 17.99% |
| Sep 30, 2022 | 10.44% |
| Jun 30, 2022 | 33.20% |
| Mar 31, 2022 | 19.76% |
| Dec 31, 2021 | 23.04% |
| Sep 30, 2021 | 15.60% |
| Jun 30, 2021 | 13.22% |
| Mar 31, 2021 | 7.70% |
| Dec 31, 2020 | 10.26% |